Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saliva Diagnostics (SALV) -- Ignore unavailable to you. Want to Upgrade?

To: s martin who wrote (3273)	11/30/1999 11:07:00 AM
From: rl	Read Replies (1) \| Respond to of 3369

Do you know for a "fact" that the CDC bought tests from SDS? I think that was touted in a press release. May have even been said by Seymour. But where's the beef? Where's Seymour? It would certainly be interesting to hear from him. I'd love his take on things now that his pet, McLaughlin, has been sacked. You know, the guy that Seymour claimed would take SDS in "new and exciting directions". Seymour the Sage. The CDC probably did like the SDS test. It is good technology. But if you can't manufacture it for a price that is viable in the areas that the CDC supports (third world), they won't buy. Don't see any sales to the CDC beefing up SDS's revenue. Of course, SDS could be making millions. We don't see the 10Ks. If there were sales to the CDC, they were minimal. But better yet, where's the millions that were going to be sold to India? Three times.